Nanjing Bohua Pharmaceutical

Nanjing Bohua Pharmaceutical Co., Ltd., a key subsidiary of Nanjing King-Friend Biochemical Pharmaceutical, is a specialized pharmaceutical company based in China. The company focuses on the research, development, and large-scale production of heparin-related products and other biochemical medicines. Its core portfolio includes Active Pharmaceutical Ingredients (APIs) and finished dosages for anticoagulants such as Heparin Sodium, Enoxaparin Sodium, and Dalteparin Sodium. Nanjing Bohua operates high-standard manufacturing facilities that comply with international GMP requirements, serving both domestic and global markets. The company plays a critical role in the supply chain for life-saving cardiovascular and hematological treatments.